Skip to main content
. 2023 May 12;55(1):2211349. doi: 10.1080/07853890.2023.2211349

Figure 4.

Figure 4.

PCP-reported treatments recommended for ongoing management of NASH and patient- reported treatments currently using. GLP-1 RAs: glucagon-like peptide-1 receptor agonist; NA: question was not asked of PCPs or patients, respectively; PCP: primary care physician; SGLT-2is: sodium-glucose cotransporter 2 inhibitors.